Meningococcal disease is endemic to the African "meningitis belt"; outbreaks occur regularly ([@R1],[@R2]). *Neisseria meningitidis* serogroup A causes most (80%) cases. However, during 2002--2003, serogroup W135 caused a major epidemic in Burkina Faso (attack rate \[AR\] 251 cases/100,000 population) ([@R3]). Thereafter, the incidence of serogroup W135 was low, with isolated cases and a small-scale outbreak in the meningitis belt ([@R4],[@R5]). In 2010, serogroup A conjugate vaccine was introduced into the African meningitis belt and substantially reduced the incidence of meningitis ([@R6]).

In The Gambia, only 6 serogroup W135 cases were identified during 1990--1995; the most recent case had been reported in 1995 ([@R7]). In 2012, a large epidemic of serogroup W135 occurred throughout the meningitis belt, including The Gambia ([@R1]). Most risk factors identified in the meningitis belt concern serogroup A ([@R8],[@R9]), and risk factors for serogroup W135 are little studied. Therefore, we report the investigation of this epidemic and the related risk factors.

The Study
=========

The Gambian Ministry of Health and the Medical Research Council Unit, The Gambia, investigated a serogroup W135 epidemic that occurred during February--June 2012 in the Central River Region (CRR) and Upper River Region (URR). Since 2008, surveillance of invasive bacterial diseases has been ongoing in Bansang Hospital in CRR and Basse Health Centre in URR ([@R10]). The peripheral health centers refer severely ill patients to these health facilities. Three approaches were used to recruit persons with suspected cases of serogroup W135: enhanced prospective surveillance in Bansang Hospital and Basse Health Centre, retrospective case identification from hospital records, and visits to households with confirmed case-patients serogroup W135 to identify other suspected cases. A suspected case was defined as a history of acute onset of fever and any of the following: altered consciousness, inability to eat, neck stiffness, seizures, petechial rash, or bulging anterior fontanel in a child \<2 years of age. Cerebrospinal fluid (CSF) and/or blood samples were collected from hospitalized persons with suspected serogroup W135. A confirmed case was a suspected case in which serogroup W135 was identified by culture and/or an antigen-specific test. The alert threshold was defined as [\>]{.ul}5 meningitis cases per 100,000 persons per week; the epidemic threshold was [\>]{.ul}10 cases ([@R11]).

The investigation team administered 1 dose of ciprofloxacin to each close contact of confirmed case-patients and provided health information to raise awareness. At the end of the epidemic, The Gambian government deployed the tetravalent meningococcal polysaccharide vaccine.

CSF and blood samples were cultured for bacteria in BACTEC Medium (Becton Dickinson, Franklin Lakes, NJ, USA) and tested for serogrouping by latex agglutination by using BACTEC and Ramel (Thermo Fisher Scientific, Waltham, MA, USA) test kits. Antimicrobial drug susceptibility was tested.

We conducted a matched case--control (ratio 1:1) study to identify risk factors. Healthy controls were matched by age and village with confirmed case-patients, including those who died. Demographic, socioeconomic, and exposure (within 14 days before illness onset) data were collected by using a structured questionnaire. Risk factors were analyzed by conducting bivariate matched and multivariate conditional logistic regression analyses. The Joint Gambia Government/Medical Research Council Ethics Committee approved the study. All study participants or legal guardians provided written informed consent.

During February 1--June 25, 2012, a total of 469 suspected cases were identified, and 114 were confirmed to be serogroup W135. Thirty-one were co-primary or secondary cases in confirmed case-patients' households. Most (67%) suspected case-patients were \<5 years of age, and 56% of cases occurred in male patients. The overall case-fatality rate was 8%.

The overall AR was 111 cases per 100,000 persons but was much higher among younger children ([Table 1](#T1){ref-type="table"}). The epidemic threshold was exceeded in the last week of February and continued until April for persons of all ages and until June for children \<5 years of age ([Figure 1](#F1){ref-type="fig"}, panels A, B). Among children \<5 years of age, the peak AR attained 83 and 47 cases per 100,000 persons per week in CRR and URR, respectively ([Figure 1](#F1){ref-type="fig"}, panel B). The epidemic peaked during the high temperature/driest months (March--May) and ended abruptly after the first rainfalls in June ([Figure 2](#F2){ref-type="fig"}).

###### Confirmed and suspected cases of *Neisseria meningitidis* serogroup W135, CRR and URR, The Gambia, February 1--June 25, 2012\*

  Health region/case-patient age group, y   Cases, no. (%)   Deaths, no. (%)   2011 population†   Cases/100,000 population
  ----------------------------------------- ---------------- ----------------- ------------------ --------------------------
  CRR                                                                                             
  \<1                                       62 (20)          8 (13)            4,216              1,470
  1--4                                      138 (45)         4 (3)             29,470             468
  5--14                                     70 (23)          2 (3)             66,545             105
  [\>]{.ul}15                               37 (12)          4 (11)            115,995            32
  Total                                     307 (100)        18 (6)            216,227            142
  URR                                                                                             
  \<1                                       47 (29)          10 (21)           4,086              1,150
  1--4                                      70 (43)          5 (7)             27,564             254
  5--14                                     36 (22)          2 (6)             64,014             56
  [\>]{.ul}15                               9 (6)            1 (11)            111,663            8
  Total                                     162 (100)        18 (11)           207,327            78
  CRR and URR                                                                                     
  \<1                                       109 (23)         18                8,302              1,312
  1--4                                      208 (44)         9                 57,034             364
  5--14                                     106 (23)         4 (4)             130,560            81
  [\>]{.ul}15                               46 (10)          5 (11)            227,658            20
  Total                                     469 (100)        36 (8)            423,554            111

\*CRR, Central River Region; URR, Upper River Region. †Estimated on the basis of 2003 census.

![Outbreak of *Neisseria meningitidis* serogroup W135, Central River and Upper River Regions, The Gambia, February 1--June 25, 2012. A) Attack rate per 100,000 persons per week. B) Attack rate per 100,000 children \<5 years of age per week. Light gray bars, Central River Region; dark gray bars, Upper River Region. Alert threshold corresponds to an attack rate of 5; epidemic threshold, to an attack rate of 10.](13-0077-F1){#F1}

![Number of epidemic cases of *Neisseria meningitidis* serogroup W135 in relation to time, temperature, humidity, and rainfall, Central River Region, The Gambia, February 1--June 25, 2012. Blue line, maximum temperature; red line, minimum temperature; green line, humidity; blue bars, total number of cases.](13-0077-F2){#F2}

The most common signs and symptoms among the 113 confirmed serogroup W135 case-patients were weakness (96%), irritability (88%), neck stiffness (81%), and inability to eat (80%). Bulging fontanelle (74%), altered mental status (73%), and seizures (65%) occurred in a slightly lower proportion of case-patients.

Blood and/or CSF samples were collected from 301 (69%) of 438 hospitalized suspected case-patients, of which almost half (138) were positive for bacterial pathogens. Serogroup W135 was the major pathogen (114 \[83%\] of 138); followed by *Streptococcus pneumoniae* (13%) and *Staphylococcus aureus* (2%). Common antibacterial drugs used for meningitis were tested on 92 (81%) serogroup W135 isolates, which were susceptible to most of them (ampicillin, 100%; chloramphenicol, 99%; ciprofloxacin, 99%; penicillin, 95%; and tetracycline, 92%) but not to erythromycin (59% susceptible) and trimethoprim/sulfamethoxazole (100% resistant).

We enrolled 106 confirmed case--control pairs. Risk factors identified in the univariate analysis were male sex, students, \>4 children 1--5 years of age in the household, contact with a meningitis case-patient, preceding history of respiratory illness (nasal discharge, difficult breathing), and itchy eyes ([Table 2](#T2){ref-type="table"}, Appendix). In the multivariate analysis, male sex (odds ratio \[OR\] 1.9; 95% CI 1.0--3.7), contact with meningitis case-patients (OR 4.8; 95% CI 1.3--17.8), difficult breathing (OR 6.8; 95% CI 1.4--33.4), and itchy eyes (OR 4.4; 95% CI 1.3--14.4) remained significantly associated with cases.

###### Matched univariate analysis for risk factors for *Neisseria meningitidis* serogroup W135 during an outbreak, Central River Region and Upper River Region, The Gambia, February 1--June 25, 2012

  Characteristic                                                                                    Cases no. (%), n = 106   Controls, no. (%), n = 106   Odds ratio (95% CI)   p value
  ------------------------------------------------------------------------------------------------- ------------------------ ---------------------------- --------------------- ---------
  Demographic                                                                                                                                                                   
  Mean age (±SD), y                                                                                 4 (3.9)                  3.9 (3.7)                                          0.876\*
  Male sex                                                                                          66 (62)                  53 (50)                      1.7 (0.96--3.1)       0.067
  Ethnic group                                                                                                                                                                  
  Mandinka                                                                                          33 (31)                  31 (29)                      Ref                   
  Sarahule                                                                                          13 (12)                  13 (12)                      0.80 (0.5--13.7)      0.881
  Fula                                                                                              44 (42)                  39 (37)                      0.64 (0.2--1.9)       0.421
  Wollof                                                                                            17 (16)                  20 (19)                      1.6 (0.3--7.7)        0.567
  Other                                                                                             1 (01)                   1 (1)                        1.0 (0.1--21.5)       0.993
  Socioeconomic                                                                                                                                                                 
  Occupation: student                                                                               22 (21)                  14 (13)                      5.0 (1.1--22.8)       0.038
  Mean age of student (±SD), y                                                                      9.8 (4.7)                9.6 (3.9)                                          0.897\*
  Primary caretaker: mother                                                                         92 (87)                  95 (90)                      0.8 (0.3--1.8)        0.523
  Occupation: farming                                                                               66 (62                   68 (64)                      0.9 (0.5--1.7)        0.73
  Formal schooling: none                                                                            90 (85)                  83 (78)                      1.5 (0.8--3.1)        0.227
  Housing                                                                                                                                                                       
  Floor earth or sand                                                                               42 (40)                  42 (40)                      1.0 (0.5--1.9)        0.769
  Roof with thatched                                                                                36 (34)                  46 (43)                      0.57 (0.3--1.1)       0.158
  Wall with mud                                                                                     68 (64)                  74 (70)                      0.63 (0.3--1.4)       0.381
  Household item                                                                                                                                                                
  Television                                                                                        22 (21)                  20 (19)                      1.2 (0.5--2.5)        0.695
  Bicycle                                                                                           82 (77)                  78 (74)                      1.3 (0.6--2.6)        0.481
  Tube well for drinking water                                                                      34 (32)                  31 (29)                      1.5 (0.5--4.2)        0.442
  Traditional pit latrine                                                                           98 (92)                  98 (92)                      1.0 (0.3--3.1)        1.0
  Travel within 14 d before illness onset                                                                                                                                       
  Hospital or health center                                                                         19 (18)                  23 (22)                      0.76 (0.37--1.6)      0.467
  Outside the village                                                                               24 (22)                  23 (22)                      1.06 (0.55--2.1)      0.866
  Festival                                                                                          21 (20)                  18 (17)                      1.2 (0.60--2.4)       0.602
  Household crowding                                                                                                                                                            
  \>1 household in participant's compound                                                           39 (37)                  40 (37)                      1.05 (0.57--1.9)      0.876
  Household member                                                                                                                                                              
  Median (interquartile range)                                                                      20 (5--79)               18 (4--51)                                         0.412
  \>20 persons in household                                                                         50 (47)                  40 (38)                      1.7 (0.88--3.3)       0.109
  Household member by age                                                                                                                                                       
  [\>]{.ul}1 children \>1 y                                                                         72 (68)                  66 (62)                      1.3 (0.72--2.5)       0.356
  \>4 children 1--5 y                                                                               59 (56)                  48 (45)                      2.1 (1.1--4.1)        0.037
  \<5 persons in sleeping room                                                                      25 (24)                  25 (24)                      1.0 (0.46--2.2)       1.00
  [\>]{.ul}1 window in sleeping room                                                                74 (70)                  64 (60)                      0.44 (0.19--1.0)      0.056
  \>3 persons sharing same room                                                                     68 (64)                  64 (60)                      1.2 (0.67--2.0)       0.572
  \>1 person sharing same bed                                                                       99 (93)                  103 (97)                     0.33 (0.07--1.6)      0.178
  Social crowding in 14 d before illness onset                                                                                                                                  
  Traveled in public transport in a week [\>]{.ul}1 d                                               8 (8)                    15 (14)                      0.54 (0.21--1.4)      0.187
  Attended gathering larger than the no. persons living in participant's compound                   37 (32)                  32 (30)                      1.1 (0.59--2.1)       0.746
  Attended school                                                                                   20 (19)                  14 (13)                      2.5 (0.78--8.0)       0.103
  Concurrent or recent respiratory or other illness within 14 d before illness onset                                                                                            
  Cough                                                                                             43 (41)                  41 (39)                      1.1 (0.59--2.1)       0.746
  Nasal discharge                                                                                   50 (47)                  30 (28)                      3.0 (1.5--6.1)        0.003
  Sore throat                                                                                       11 (11)                  6 (6)                        2.0 (0.68--5.9)       0.206
  Difficult breathing                                                                               17 (16)                  5 (5)                        7.0 (1.6--30.8)       0.010
  Itchy eyes                                                                                        18 (17)                  4 (4)                        4.5 (1.5--13.3)       0.007
  Itchy nose                                                                                        10 (10)                  3 (3)                        3.3 (0.91--12.1)      0.067
  Itchy throat                                                                                      4 (4)                    3 (3)                        1.3 (0.03--5.9)       0.706
  Ear infection                                                                                     9 (9)                    6 (6)                        1.6 (0.52--4.9)       0.410
  Diarrhea                                                                                          36 (34)                  27 (26)                      1.8 (0.86--3.6)       0.122
  Symptoms of respiratory infection (cough, nasal discharge or difficult breathing)                 61 (58)                  53 (50)                      1.5 (0.80--2.8)       0.209
  Contact with patients who have symptoms of meningoencephalitis within 14 d before illness onset                                                                               
  Knew any person with fever with convulsion, altered mental status or unconsciousness              22 (21)                  18 (17)                      1.4 (0.62--3.2)       0.416
  Contact (within 1 m) with any person with symptoms of meningoencephalitis                         15 (15)                  6 (6)                        4.0 (1.1--14.1)       0.032
  Site of contact                                                                                                                                                               
  No contact                                                                                        91 (86)                  100 (94)                     1                     
  Contact outside compound                                                                          8 (8)                    4 (4)                        2.9 (0.70--12.4)      0.142
  Contact in household and compound                                                                 7 (7)                    1 (2)                        7.4 (0.84--65.0)      0.072
  Exposure to smoke within 14 d before illness onset                                                                                                                            
  Any person smoked cigarette or other tobacco products in household                                58 (55)                  57 (54)                      1.04 (0.58--1.9)      0.882
  Kitchen inside living room or veranda                                                             5 (5)                    2 (2)                        4.0 (0.45--35.8)      0.215
  Exposed to cooking smoke during cooking                                                           86 (81)                  78 (74)                      1.7 (0.82--3.6)       0.149
  Carried children (\<2 y) on the back whiule cooking, n = 74                                       24 (65)                  20 (54)                      1.6 (0.60--4.6)       0.323
  Used mosquito repellent or fires to keep body warm                                                10 (9.4)                 5 (4.7)                      2.7 (0.71--10.1)      0.147
  Child currently breast-feeding                                                                    31 (29)                  37 (35)                      0.25 (0.05--1.2)      0.080

\*p value by Wilcoxon rank-sum (Mann-Whitney) test.

Conclusions
===========

Before the current cases, the most recent sporadic cases in The Gambia were reported in the early 1990s. These cases were part of a larger epidemic in the meningitis belt with a comparable predominance of serogroup W135 followed by *S. pneumoniae* ([@R1]). After introduction of MenAfriVac (serogroup A conjugate vaccine), incidence and epidemics caused by serogroup A decreased substantially in the meningitis belt ([@R6],[@R12]). The reemergence of epidemic serogroup W135 in this region requires a strategy for surveillance, epidemic detection and control, and revised vaccination policy.

Serogroup A outbreaks usually affect children \>5 years of age and young adults ([@R5],[@R13],[@R14]). However, two thirds of the serogroup W135 cases occurred in children \<5 years of age, for whom the AR was 5-fold higher than it was for older age groups, similar to the characteristics of the serogroups W135 outbreaks in Burkina Faso (2002--2003) and Niger (2010) ([@R3],[@R5]). Therefore, the current operational definition of alert and epidemic thresholds, drawn mostly from serogroup A data, should be revised because merging the AR for all age groups may delay, or result in nondetection of, a serogroup W135 epidemic in younger age groups.

Signs and symptoms of concurrent respiratory illness were more prevalent among case-patients than controls;, itchy eyes and difficult breathing were associated with disease. The temporal sequence of these signs relative to the occurrence of meningococcal disease was not determined, and whether these factors facilitated the invasion of serogroup W135 carried in the nasopharynx or whether these symptoms were part of the initial serogroup W135 infection before onset of severe disease is unclear. Contact with confirmed serogroup W135 case-patients was a strong risk factor. These results are consistent with information available for the other serogroups and with the route of serogroup W135 transmission through droplet infection ([@R15]).

Our findings suggest that isolation of case-patients and prophylactic treatment of contacts may reduce transmission of meningococcal disease during epidemics. Enhanced surveillance for meningitis is recommended for early detection of epidemics. The occurrence of this large serogroup W135 outbreak suggests that multiserogroup conjugate vaccine should be deployed for control and prevention.
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